As healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Brian Nightengale, PhD
Advertisement
Articles by Brian Nightengale, PhD
Advertisement
Latest Updated Articles
- Review of Outcomes Associated With Formulary Restrictions: Focus on Step Therapy
Published: April 6th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
3
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
4
A Defining Moment for Health System Pharmacy: Advancing Competency, Policy, and Patient Need in 2026
5